NCT00462761 2020-05-11A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 StatusDaiichi SankyoPhase 1 Completed76 enrolled 12 charts
NCT01849276 2019-01-31Metformin+Cytarabine for the Treatment of Relapsed/Refractory AMLNorthwestern UniversityPhase 1 Terminated2 enrolled 9 charts